812 results on '"Yki-Järvinen, H"'
Search Results
2. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease
3. Non-alcoholic fatty liver disease and risk of type 2 diabetes
4. The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality
5. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease
6. Advancing the global public health agenda for NAFLD: a consensus statement
7. Gene Expression and Immunohistochemistry in Adipose Tissue of HIV Type 1–Infected Patients with Nucleoside Analogue Reverse-Transcriptase Inhibitor–Associated Lipoatrophy
8. Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes
9. Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extension
10. Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes
11. One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension
12. Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes
13. Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3
14. Lipogenic Thrsp as a regulator of adipocyte metabolism
15. Corrigendum to: 'Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort'☆ (J Hepatol [2020] 505–515) (Journal of Hepatology (2020) 73(3) (505–515), (S0168827820302130), (10.1016/j.jhep.2020.04.003))
16. Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly
17. A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans
18. Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations
19. NR1H4 rs35724 G>C variant modulates liver damage in nonalcoholic fatty liver disease
20. Tissue specificity of insulin resistance in humans: fat in the liver rather than muscle is associated with features of the metabolic syndrome
21. Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance
22. Overproduction of large VLDL particles is driven by increased liver fat content in man
23. Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects
24. Increased augmentation of central blood pressure is associated with increases in carotid intima–media thickness in type 2 diabetic patients
25. In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing’s syndrome is associated with increased regeneration of cortisol by 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue
26. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk
27. Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance
28. CB1 blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans
29. Family histories of Type II diabetes and hypertension predict intima–media thickness in patients with Type I diabetes
30. Type 2 diabetes: remission in just a week
31. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus
32. Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
33. Complex interactions of genetic and lifestyle effects on subcutaneous abdominal adipocyte size in healthy young adult twins: T1:OS2.6
34. Inaccuracies in food and physical activity diaries of obese subjects: complementary evidence from doubly labeled water and co-twin assessments
35. Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
36. Insulin resistance characterizes glucose uptake in skeletal muscle but not in the heart in NIDDM
37. Insulin-induced vasodilatation: physiology or pharmacology?
38. Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes
39. Insulin resistance due to hyperglycaemia: an adaptation protecting insulin-sensitive tissues
40. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM
41. UDP-N-acetylglucosamine transferase and glutamine: fructose 6-phosphate amidotransferase activities in insulin-sensitive tissues
42. Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects
43. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM
44. Increased expression of the macrophage markers and of 11β-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity
45. Role of insulin resistance in the pathogenesis of NIDDM
46. Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects
47. Insulin resistance and the fatty liver in humans: A1771
48. Metabolomics in monozygotic twins - new aspects in the lipid metabolism of obesity: OP0164
49. Nature or nurture? A genome-wide gene expression study in monozygotic twins discordant for obesity: OP0097
50. Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.